BP Agrees Sale of Alabama Complex to Indorama

BP has agreed to sell its petrochemical complex in Decatur, Alabama, USA, to Thai PET producer Indorama Ventures, the global market leader. Indorama’s AlphaPet PET plant is co-located on the Decatur site, with BP supplying paraxylene (PX) and purified terephthalic acid (PTA) feedstock.

The site was put up for sale last November as BP decided to refocus its global business in a bid to improve profitability and long-term growth.

Financial terms were not disclosed but the transaction is expected to close early in 2016. Indorama will also assume certain contracts with suppliers and customers as part of the deal.

Rita Griffin, chief operating officer of BP Global Petrochemicals, said the agreement would allow it to focus investments on its PTA plant in Cooper River, South Carolina, which is currently being upgraded, as well as a key producer of PTA feedstock in Texas City, Texas.

Indorama has been steadily building its PET base for several years and most recently has sought back-integration into PTA. The most recent deals include the December 2015 announcement of plans to buy Indian PET producer MicroPet and the acquisition a month earlier of competitor CEPSA’s PTA/PET assets in Spain.

BP said it expects to make divestments worth between $3-5 billion in 2016, along with ongoing divestments averaging around $2-3 billion per year thereafter.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.